|
FAM115A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.23409999994462E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.062000E-03 |
| Normal-vs-Stage2 |
3.081300E-03 |
| Normal-vs-Stage3 |
1.70960000045461E-07 |
| Normal-vs-Stage4 |
3.85000000000524E-05 |
| Stage1-vs-Stage2 |
2.436600E-01 |
| Stage1-vs-Stage3 |
1.582380E-03 |
| Stage1-vs-Stage4 |
1.568370E-02 |
| Stage2-vs-Stage3 |
2.570800E-01 |
| Stage2-vs-Stage4 |
4.235600E-01 |
| Stage3-vs-Stage4 |
8.012400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39979999999695E-05 |
| Normal-vs-AfricanAmerican |
3.83780000001721E-06 |
| Normal-vs-Asian |
9.388000E-01 |
| Caucasian-vs-AfricanAmerican |
9.635900E-02 |
| Caucasian-vs-Asian |
2.918200E-01 |
| AfricanAmerican-vs-Asian |
7.521700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.98439999996325E-06 |
| Normal-vs-Female |
2.983900E-04 |
| Male-vs-Female |
5.264400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.913200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.845300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.34389999997919E-06 |
| Normal-vs-Age(81-100Yrs) |
1.54105999999876E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.636400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.813200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.005220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.908100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.047360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.534600E-01 |
| Normal-vs-Grade 2 |
9.221600E-03 |
| Normal-vs-Grade 3 |
6.49490000004249E-07 |
| Normal-vs-Grade 4 |
2.88730000019832E-07 |
| Grade 1-vs-Grade 2 |
2.242000E-01 |
| Grade 1-vs-Grade 3 |
2.066000E-02 |
| Grade 1-vs-Grade 4 |
5.175000E-03 |
| Grade 2-vs-Grade 3 |
1.175880E-02 |
| Grade 2-vs-Grade 4 |
1.559520E-03 |
| Grade 3-vs-Grade 4 |
1.219800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.620500E-02 |
| Normal-vs-ccB subtype |
9.90969999999924E-05 |
| ccA subtype-vs-ccB subtype |
4.773600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.60310000000474E-05 |
| Normal-vs-N1 |
7.838700E-03 |
| N0-vs-N1 |
6.294400E-01 |
|
|
